Skip to main navigation
Top Links - Left
BioNTech.com
Medienbereich
Investoren
Medizinisches Fachpersonal
Deutsch
Language switcher (Content)
English
German
Top Links - Right
Kontakt
Main Navigation
BioNTech.com
Pressemitteilungen
Events und Präsentationen
Finanzberichte
Finanzberichte
SEC Filings
Jahresberichte
Quartalsberichte
Finanzkalender
Corporate Governance
Corporate Governance
Übersicht
Transparency
ESG
Aktieninformationen
Aktieninformationen
Aktienkurs
Analysten
Warnung vor Aktionärsbetrug
Rückkaufprogramm für ADS
Informationen zur Dividende
Investor FAQs
Hauptversammlung
Hauptversammlung
Ordentliche Hauptversammlung 2024
Hauptversammlung Archiv
Kontakt
Medienbereich
Investoren
Medizinisches Fachpersonal
Breadcrumb
Investoren
Suchen
Suche
Filter by content type
(-)
Posten
(881)
Filter by content year
2024
(67)
2023
(137)
2022
(322)
2021
(112)
2020
(168)
2019
(17)
2018
(6)
2017
(2)
2016
(10)
2015
(11)
Filter by form group
Filter by category
Filter by category
Search
Posten
Q3 2020 Presentation
Q3 2020 Presentation
1.4 MB
Posten
BNTX 3Q 2020 Presentation
BNTX 3Q 2020 Presentation
1.4 MB
Posten
Q3 2020 Financial Report
Q3 2020 Financial Report
463.3 KB
Posten
BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China
PDF Version
153.7 KB
Posten
BioNTech COVID-19 Vaccine Vial 1
BioNTech COVID-19 Vaccine Vial 1
5.8 MB
Posten
BioNTech COVID-19 Vaccine Vial 1
BioNTech COVID-19 Vaccine Vial 1
5.8 MB
Posten
BioNTech COVID-19 Vaccine Vial 2
BioNTech COVID-19 Vaccine Vial 2
2.6 MB
Posten
BioNTech COVID-19 Vaccine Vial 2
BioNTech COVID-19 Vaccine Vial 2
2.6 MB
Posten
BioNTech COVID-19 Vaccine Vial 3
BioNTech COVID-19 Vaccine Vial 3
6.2 MB
Posten
BioNTech COVID-19 Vaccine Vial 3
BioNTech COVID-19 Vaccine Vial 3
6.2 MB
Pagination
Page 1
Next page
››